Bharat Biotech's Covaxin is overall 77.8 per cent effective "against symptomatic COVID-19", the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The...
source https://www.ndtv.com/india-news/covaxin-overall-77-8-effective-claims-bharat-biotech-in-final-phase-3-data-yet-to-be-peer-reviewed-2478189
No comments:
Post a Comment